Earlier this month, HHS was working on an aggressive deadline. President Joe Biden had given them 45 days to develop a comprehensive plan to lower drug prices, and the clock was ticking. HHS asked stakeholders across the spectrum to provide input during a special roundtable discussion. Guess who they called from pharmacy?

WASHINGTON, DC— Vertically merged pharmacy benefit managers (PBMs) use their highly concentrated market power to dominate, deceive, and maybe even defraud, American Pharmacists Association (APhA) CEO and Executive Vice President Scott Knoer told Federal Trade Commission (FTC) leaders at a roundtable today.

September 9, 2021, was a busy day for the federal government and pharmacy stakeholders alike: Just a few hours apart, we saw significant developments in pharmacists’ COVID-19 pandemic practice authorities and prescription drug pricing. Both items yielded positive news for pharmacists and their patients.

In a recent conversation with a patient’s wife, Justin Ruffridge, PharmD, learned a lot more about the patient’s condition than he expected.